Navigation Links
Gallo Research Center announces new round of awards for $20m US Army-funded research program

The UCSF-affiliated Ernest Gallo Clinic and Research Center has issued a second round of grants under its U.S. Army-funded research program intended to accelerate the discovery and development of new medications to treat alcohol and substance abuse in the context of post-traumatic stress and combat injury.

The program, known as the Institute for Molecular Neuroscience (IMN), relies on the expertise of a team of national experts who are unaffiliated with grant applicants to conduct an independent peer-review process.

The second round of pilot research grants will support a broad range of projects to investigate potential new treatments for substance abuse, traumatic brain injury and post-traumatic stress. The total funding for this round of awards is $1.25 million. Together with the $3.7 million awarded in round one, the IMN has to date awarded approximately $5 million in proof-of-principle grants.

The IMN Program represents an important new strategy for combating substance abuse and related post-traumatic stress or other combat injuries, said John A. De Luca, PhD, chairman of the board and president of the Gallo Center. These medical conditions are national security health issues. The IMN seeks to address these problems through its multidisciplinary, competitive national research program.

Grant recipients in this round of funding are:

Michael E. Charness

Boston VA Research Institute (Harvard)


Lori A. Knackstedt

University of Florida


Kenneth M. Lattall

Oregon Health and Science University


Eric P. Zorilla

The Scripps Research Institute


It is gratifying that Congress and the Defense Department have embraced the IMN Program and its new approach to accelerating the discovery of new medications to address substance abuse, post-traumatic stress and other conditions facing our military personnel and veterans, said William R. Sawyers, chief administrative officer of the IMN and the Gallo Center.

The UCSF-affiliated Gallo Research Center was selected to manage the IMN Program in recognition of its expertise in the neurobiology of addiction and in managing large research projects. The strategy of the IMN, which funds short-term pilot projects, and then selects only the most compelling for advancement, represents a new approach to the development of medications for the U.S. Military.

The IMN Program is comprised of a consortium of 18 leading research universities and research institutions across the country. Institutions which have received IMN funding previously include Columbia University, Oregon Health and Science University, the Medical University of South Carolina, Yale University, the University of Texas, Austin, the Northern California Institute for Research and Education (NCIRE) and UCSF.

Congressional appropriations for the IMN Program to date total $20.1 million, said De Luca. Later this year, the IMN will select the most promising of its first round of pilot projects to be advanced into the next stage of medications development, said Sawyers.


Contact: Peter Farley
University of California - San Francisco

Related medicine news :

1. Gallo Research Center to lead $15 million US Army-funded national research program
2. Increasing dopamine in frontal cortex decreases impulsive tendency, UCSF-Gallo scientists find
3. Increasing dopamine in brains frontal cortex decreases impulsive tendency, UCSF-Gallo study finds
4. Does gallows humor among physicians encourage accusations of murder and euthanasia?
5. A Milestone: Pool Services Technologies Just Conserved 7.5 Million Gallons of Water in San Diego
6. Gallo Center study in mice links cocaine use to new brain structures
7. Automotive Paints Market Worth 998.7 Million Gallons by 2018 with Revenue of $11.7 Billion - New Report by MarketsandMarkets
8. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
9. NIH awards $20 million over 5 years to train next generation of global health researchers
10. Researchers develop a new cell and animal model of inflammatory breast cancer
11. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
Post Your Comments:
Related Image:
Gallo Research Center announces new round of awards for $20m US Army-funded research program
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
Breaking Medicine Technology: